U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867223) titled 'Nanoparticle-Based Prunus Salicina Extract vs. Clotrimazole for Otomycosis' on Oct. 05.
Brief Summary: This randomized controlled superiority trial evaluates the anti-otomycotic efficacy of Prunus salicina methanolic extract in two formulations (standard drops and chitosan nanoparticle-based drops) compared to standard 1% clotrimazole drops in patients diagnosed with otomycosis.
Study Start Date: July 15, 2025
Study Type: INTERVENTIONAL
Condition:
Otomycosis
Antifungal Agents
Intervention:
DRUG: Group A
Clotrimazole 1% ear drops: Aqueous solution of 200 mg clotrimazole in sterile saline (9 mg/mL NaCl). Drops applied to affect...